JP2002363097A5 - - Google Patents

Download PDF

Info

Publication number
JP2002363097A5
JP2002363097A5 JP2001312701A JP2001312701A JP2002363097A5 JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5 JP 2001312701 A JP2001312701 A JP 2001312701A JP 2001312701 A JP2001312701 A JP 2001312701A JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5
Authority
JP
Japan
Prior art keywords
composition according
composition
pharmaceutically acceptable
stabilizer
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001312701A
Other languages
English (en)
Japanese (ja)
Other versions
JP4691866B2 (ja
JP2002363097A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001312701A priority Critical patent/JP4691866B2/ja
Priority claimed from JP2001312701A external-priority patent/JP4691866B2/ja
Publication of JP2002363097A publication Critical patent/JP2002363097A/ja
Publication of JP2002363097A5 publication Critical patent/JP2002363097A5/ja
Application granted granted Critical
Publication of JP4691866B2 publication Critical patent/JP4691866B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001312701A 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物 Expired - Lifetime JP4691866B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001312701A JP4691866B2 (ja) 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18771399 1999-07-01
JP11-187713 1999-07-01
JP1999187713 1999-07-01
JP2001312701A JP4691866B2 (ja) 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001507492A Division JP3381722B2 (ja) 1999-07-01 2000-06-29 安定化された凍結乾燥型医薬組成物

Publications (3)

Publication Number Publication Date
JP2002363097A JP2002363097A (ja) 2002-12-18
JP2002363097A5 true JP2002363097A5 (https=) 2007-06-14
JP4691866B2 JP4691866B2 (ja) 2011-06-01

Family

ID=16210881

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001507492A Expired - Lifetime JP3381722B2 (ja) 1999-07-01 2000-06-29 安定化された凍結乾燥型医薬組成物
JP2001312701A Expired - Lifetime JP4691866B2 (ja) 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001507492A Expired - Lifetime JP3381722B2 (ja) 1999-07-01 2000-06-29 安定化された凍結乾燥型医薬組成物

Country Status (28)

Country Link
US (2) US6774104B1 (https=)
EP (1) EP1107777B1 (https=)
JP (2) JP3381722B2 (https=)
KR (1) KR100454784B1 (https=)
CN (2) CN1179748C (https=)
AR (1) AR024634A1 (https=)
AT (1) ATE280583T1 (https=)
AU (1) AU752265B2 (https=)
BR (2) BRPI0006823B8 (https=)
CA (1) CA2341568C (https=)
CZ (1) CZ295720B6 (https=)
DE (1) DE60015279T2 (https=)
ES (1) ES2225161T3 (https=)
HK (1) HK1040057B (https=)
HU (1) HU229089B1 (https=)
ID (1) ID29468A (https=)
IL (2) IL141455A0 (https=)
MX (1) MXPA01000601A (https=)
NO (1) NO330353B1 (https=)
NZ (1) NZ510290A (https=)
OA (1) OA11601A (https=)
PL (1) PL200141B1 (https=)
PT (1) PT1107777E (https=)
RU (1) RU2251411C2 (https=)
TR (1) TR200100609T1 (https=)
TW (1) TWI233805B (https=)
WO (1) WO2001002002A1 (https=)
ZA (1) ZA200101589B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
AU2003252746A1 (en) 2002-07-31 2004-02-16 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
MXPA05005338A (es) * 2002-11-18 2005-12-14 Vicuron Pharm Inc Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1721610B1 (en) 2004-03-04 2009-05-13 Eisai R&D Management Co., Ltd. Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
US7514450B2 (en) * 2004-05-19 2009-04-07 Neurosearch A/S Azabicyclic aryl derivatives
AU2005306579B2 (en) * 2004-11-22 2012-01-19 Immuron Limited Bioactive compositions
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
WO2007010995A1 (ja) * 2005-07-20 2007-01-25 Kyowa Medex Co., Ltd. 生体試料中のペプチドの安定化方法
CN1962852B (zh) * 2006-11-27 2011-11-09 西北农林科技大学 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法
CN102614491B (zh) * 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
PE20150683A1 (es) * 2012-05-22 2015-06-03 Paion Uk Ltd Composiciones que comprenden benzodiazepinas de accion corta
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
DK2893929T3 (da) 2013-03-15 2025-07-07 Merck Sharp & Dohme Llc Antibiotisk ceftolozansammensætninger
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
CN103330932B (zh) * 2013-04-26 2015-12-23 江苏豪森药业股份有限公司 一种米卡芬净或其盐的药物组合物
CN103330933B (zh) * 2013-04-26 2015-08-05 江苏豪森药业股份有限公司 含有米卡芬净或其盐的药物组合物
EP3003298B1 (en) * 2013-06-05 2024-03-20 The University Of British Columbia Anti-fibrogenic compounds, methods and uses thereof
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101611349B1 (ko) 2014-04-14 2016-04-12 신우철 안정성이 개선된 밀크씨슬 엑스의 제형
JP7109189B2 (ja) * 2014-05-29 2022-07-29 シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッド シクロペプチド系化合物の組成物およびその製造方法と使用
RU2732129C2 (ru) * 2014-12-05 2020-09-11 Мейдзи Сейка Фарма Ко., Лтд. Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированного препарата
ES2777942T3 (es) * 2014-12-31 2022-04-22 Galenicum Health S L U Composiciones farmacéuticas estables que comprenden micafungina
ES2694561T3 (es) 2015-02-23 2018-12-21 Selectchemie Ag Composición de anidulafungina
EP3554474B1 (en) 2016-12-16 2023-12-06 Baxter International Inc. Micafungin compositions
WO2019005829A1 (en) * 2017-06-26 2019-01-03 Wayne State University METHODS AND COMPOSITIONS RELATING TO CANCER DEPENDENT ON HORMONE RECEPTORS
RU2666148C1 (ru) * 2017-10-05 2018-09-06 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH03240727A (ja) 1990-02-15 1991-10-28 Toyo Jozo Co Ltd ニューモシスチス・カリニ肺炎治療剤
IE990233A1 (en) * 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
JP3193735B2 (ja) 1991-07-24 2001-07-30 株式会社リコー カラー画像形成装置の搬送装置
RU2095081C1 (ru) * 1991-12-13 1997-11-10 Акционерное общество "Биофа" Фармацевтическая композиция антивирусного действия
JPH0651641A (ja) 1992-07-30 1994-02-25 Olympus Optical Co Ltd 湿式現像装置
JPH06172204A (ja) * 1992-12-09 1994-06-21 Asahi Chem Ind Co Ltd アクレアシン類含有リポソーム製剤およびその製造法
JP3240727B2 (ja) 1993-02-25 2001-12-25 ソニー株式会社 偏平型陰極線管の画像歪補正装置
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
AU681119B2 (en) * 1993-05-17 1997-08-21 Fujisawa Pharmaceutical Co., Ltd. New polypeptide compound and a process for preparation thereof
WO1996011210A1 (en) * 1994-10-07 1996-04-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
DE69739532D1 (de) * 1996-03-08 2009-09-24 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
JPH09301997A (ja) 1996-05-17 1997-11-25 Yamanouchi Pharmaceut Co Ltd 新規環状ペプチド系化合物
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
JPH10279498A (ja) * 1997-04-07 1998-10-20 Nippon Shinyaku Co Ltd 慢性関節リウマチ治療剤
JP3544847B2 (ja) * 1998-01-16 2004-07-21 三菱電機株式会社 光学的情報再生方法および装置
EP1582204B1 (en) * 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
WO2000051567A1 (en) * 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent

Similar Documents

Publication Publication Date Title
JP2002363097A5 (https=)
RU2001108569A (ru) Стабилизированная фармацевтическая композиция в лиофилизированной форме
JP3623962B2 (ja) ヒドロキソコバラミンの鼻中投与用医薬組成物
CA2341568A1 (en) Stabilized pharmaceutical composition in lyophilized form
CA2288143A1 (en) Activated protein c formulations
JP2003506416A5 (https=)
JP2006516648A5 (https=)
JP2004509061A5 (https=)
JP2004504406A5 (https=)
JP2010523714A5 (https=)
JPWO2019107530A1 (ja) 炎症性腸疾患の治療薬
JP2003532640A5 (https=)
KR100546450B1 (ko) 약학 조성물
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
KR20220081311A (ko) 니클로사마이드를 포함하는 근육내 및/또는 피하 투여용 약학적 조성물
JP2002509154A5 (https=)
JP4752987B2 (ja) 外用剤組成物
JP2002080490A (ja) 新規ヌクレオシド
US5925625A (en) Pharmaceutical composition for the intranasal administration of hydroxocobalamin
JP2001322936A (ja) 眼科用組成物
US10308937B2 (en) Combination long acting compositions and methods for Hepatitis C
US20170333460A1 (en) Long acting pharmaceutical compositions for hepatitis c
WO2003026570A3 (en) Reduced toxicity cisplatin formulations and methods for using the same
JP5514270B2 (ja) アシタザノラスト含有組成物
JPH0678241B2 (ja) ｔＰＡ医薬組成物